Here, we report that the LINE-1 methylation level, a surrogate marker for the global DNA methylation status, is markedly lower in IDH-mutant astrocytomas of CNS WHO grade 4 compared with lower-grade tumors. This evidence concerns the gene IDH2 and astrocytoma (excluding glioblastoma).